Callan JMB Inc. Receives Nasdaq Deficiency Notice for Stockholders’ Equity
Key Points:
- Callan JMB Inc. (Nasdaq: CJMB) has received a formal deficiency notice from the Nasdaq Stock Market LLC.
- The notice was issued on April 7, 2026, by the Listing Qualifications Department of Nasdaq.
- The company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of \$2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital Market.
- Despite the deficiency, trading of CJMB’s common stock will continue on Nasdaq under the ticker “CJMB” for the time being.
- The company has not yet regained compliance, and there is no assurance its plan to do so will be accepted or successful.
Details for Investors
On April 7, 2026, Callan JMB Inc. announced it has received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The notice states that Callan JMB is not in compliance with Nasdaq Listing Rule 5550(b)(1). This rule requires listed companies to maintain a minimum of \$2.5 million in stockholders’ equity to remain on The Nasdaq Capital Market.
Immediate Impact: The company’s non-compliance does not have an immediate effect on the listing or trading of its common stock. Shares of Callan JMB Inc. will continue to trade under the ticker symbol CJMB on Nasdaq. However, the company must act to regain compliance, and there is no guarantee that its plan will be approved by Nasdaq or that the company will be able to meet the listing requirements within the prescribed period.
Possible Future Actions and Risks:
- The company intends to submit a plan to Nasdaq to regain compliance with the stockholders’ equity requirement within 45 calendar days from the date of the notice.
- If Nasdaq accepts the company’s plan, Callan JMB may be granted up to 180 calendar days from the date of the notice to regain compliance.
- If the plan is not accepted or the company fails to meet the requirement within the compliance period, its shares may be subject to delisting from The Nasdaq Capital Market.
- This uncertainty may increase volatility in the company’s share price, and the risk of a potential delisting could significantly impact shareholder value.
Forward-Looking Statements and Risks
The company has issued a cautionary statement regarding forward-looking statements. These include risks related to its ability to implement strategic initiatives, supply chain disruptions, regulatory compliance, legal proceedings, and broader economic and financial conditions. There is an explicit warning that actual results could differ materially from those projected or implied in forward-looking statements.
What Shareholders Need to Know
- This notice is a material event and may be considered price sensitive, as it could ultimately result in the company’s shares being delisted from Nasdaq, subject to the company’s response and Nasdaq’s acceptance of any remediation plan.
- While trading continues, the company’s ability to regain compliance is uncertain, and there can be no assurance that it will be successful in maintaining its Nasdaq listing.
- Investors should monitor upcoming announcements from the company regarding its compliance plan and any updates from Nasdaq.
Security Details
- Company Name: Callan JMB Inc.
- Trading Symbol: CJMB
- Exchange: The Nasdaq Stock Market LLC
- Class of Security: Common Stock, \$0.001 par value
- Company Address: 244 Flightline Drive, Spring Branch, TX 78070
- Phone: (830) 438-0395
- SEC File Number: 001-42506
- Emerging Growth Company: Yes
Disclaimer: This article contains forward-looking statements, which involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. This is not investment advice. Investors should review official filings and consult with professional advisors before making investment decisions. The company undertakes no obligation to update forward-looking statements except as required by law.
View CALLAN JMB INC. Historical chart here
